Marty Makary

And in that role, some people have left

the FDA, and then they've been outspoken critics of yourself.

the FDA, and then they've been outspoken critics of yourself.

Maybe you can respond to some of the criticisms, that it's chaotic, that there's a lot of turmoil.

Maybe you can respond to some of the criticisms, that it's chaotic, that there's a lot of turmoil.

I've worked at many startups.

I've worked at many startups.

I know that when you move fast, things feel, or they may feel too busy, or they may feel like there's too much going on.

I know that when you move fast, things feel, or they may feel too busy, or they may feel like there's too much going on.

It's overwhelming at times, but at the end of the day, progress is what matters.

It's overwhelming at times, but at the end of the day, progress is what matters.

Maybe you could just comment on some of the reports made by employees that have quit the FDA, left, and provided some comments on how things are going.

Maybe you could just comment on some of the reports made by employees that have quit the FDA, left, and provided some comments on how things are going.

Great.

Great.

Well, look, let's start with a framing.

Well, look, let's start with a framing.

The framing is the US versus China.

The framing is the US versus China.

I want to read this report that came from the Congressional National Security Commission on Emerging Biotechnology.